Prunetinoside Inhibits Lipopolysaccharide-Provoked Inflammatory Response via Suppressing NF-κB and Activating the JNK-Mediated Signaling Pathway in RAW264.7 Macrophage Cells |
| |
Authors: | Abuyaseer Abusaliya Pritam Bhagwan Bhosale Hun Hwan Kim Sang Eun Ha Min Yeong Park Se Hyo Jeong Preethi Vetrivel Joon-Suk Park Gon Sup Kim |
| |
Affiliation: | 1.Research Institute of Life Science, Department of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Korea; (A.A.); (P.B.B.); (H.H.K.); (S.E.H.); (M.Y.P.); (S.H.J.);2.Department of Pharmacy, National University of Singapore, Singapore 117643, Singapore;3.Preclinical Research Center, Daegu-Gyeonbuk Medical Innovation Foundation (DGMIF), Daegu 41061, Korea; |
| |
Abstract: | Inflammation is a multifaceted response of the immune system at the site of injury or infection caused by pathogens or stress via immune cells. Due to the adverse effects of chemical drugs, plant-based compounds are gaining interest in current research. Prunetinoside or prunetin-5-O-glucoside (PUG) is a plant-based active compound, which possesses anti-inflammatory effects on immune cells. In this study, we investigate the effect of PUG on mouse macrophage RAW264.7 cells with or without stimulation of lipopolysaccharide (LPS). Cytotoxicity results showed that PUG is non-cytotoxic to the cells and it reversed the cytotoxicity in LPS-stimulated cells. The levels of nitric oxide (NO) and interleukin-6 (IL-6) were determined using a NO detection kit and IL-6 ELISA kit, respectively, and showed a significant decrease in NO and IL-6 in PUG-treated cells. Western blot and qRT-PCR were performed for the expression of two important pro-inflammatory cytokines, COX2 and iNOS, and found that their expression was downregulated in a dose-dependent manner. Other pro-inflammatory cytokines, such as IL-1β, IL-6, and TNFα, had reduced mRNA expression after PUG treatment. Furthermore, a Western blot was performed to calculate the expression of NF-κB and MAPK pathway proteins. The results show that PUG administration dramatically reduced the phosphorylation of p-Iκbα, p-NF-κB 65, and p-JNK. Remarkably, after PUG treatment, p-P38 and p-ERK remain unchanged. Furthermore, docking studies revealed that PUG is covalently linked to NF-κB and suppresses inflammation. In conclusion, PUG exerted the anti-inflammatory mechanism by barring the NF-κB pathway and activating JNK. Thus, prunetinoside could be adopted as a therapeutic compound for inflammatory-related conditions. |
| |
Keywords: | prunetinoside, anti-inflammatory, NF-κ B pathway, MAPK pathway |
|
|